Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Payables (2023 - 2025)

Rallybio (RLYB) has disclosed Payables for 3 consecutive years, with $126000.0 as the latest value for Q4 2025.

  • Quarterly Payables fell 54.68% to $126000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $126000.0 through Dec 2025, down 54.68% year-over-year, with the annual reading at $126000.0 for FY2025, 54.68% down from the prior year.
  • Payables hit $126000.0 in Q4 2025 for Rallybio, down from $269000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.2 million in Q2 2024 to a low of $119000.0 in Q2 2025.
  • Historically, Payables has averaged $531166.7 across 3 years, with a median of $467000.0 in 2023.
  • Biggest five-year swings in Payables: surged 76.78% in 2024 and later plummeted 90.23% in 2025.
  • Year by year, Payables stood at $976000.0 in 2023, then plummeted by 71.52% to $278000.0 in 2024, then plummeted by 54.68% to $126000.0 in 2025.
  • Business Quant data shows Payables for RLYB at $126000.0 in Q4 2025, $269000.0 in Q3 2025, and $119000.0 in Q2 2025.